Clik here to view.
PharmaEngine Announces Phase 2 PEPCOL Study Presented at the 2015 ASCO GI of...
TAIPEI, Taiwan PharmaEngine, Inc. (TWO:4162) today announced that the data from the randomized non-comparative phase 2 PEPCOL study of PEP02 (MM-398, liposome irinotecan injection) in unresectable...
View ArticleClik here to view.
Not for the Faint of CAR-T: The CAR-T Therapy Landscape in 2015
LONDON & BOSTON & TOKYO The market interest surrounding anti-tumour CAR-T therapies was one of the defining themes of 2014 and investor enthusiasm for the area is unlikely to abate in 2015....
View ArticleClik here to view.
Dr. Jeremy Levin & Prof. (Dr.) Vijay Kuchroo Join Biocon’s Board of Directors
BANGALORE, India Biocon Ltd, an emerging global biopharmaceutical enterprise and India’s largest fully-integrated biotech company, has expanded its Board of Directors with the induction of two...
View ArticleClik here to view.
Life Sciences Hiring Index Posts Slight Decline to End Record Year
WEST ORANGE, N.J. ZRG Partners, Inc. has announced the final findings for 2014 with their fourth quarter Global Life Sciences Hiring Index. Despite a small drop from Q3, 2014 ended with the highest...
View ArticleClik here to view.
ENMORE: Immunotherapy Industry Summit 2015 — Cellular Immunotherapy Focus
SHANGHAI With the development of clinical translation, the immunotherapy industry, especially the cellular immunotherapy, is gaining popularity as an emerging biotherapy method. On April 10-11,...
View ArticleClik here to view.
THERAVECTYS Obtains Orphan Drug Designation from the European Medicines...
PARIS “On World Cancer Day 2015, we are proud to be one of the most innovative players in the immuno-oncology space, developing a new kind of treatment for more sustainable remission. In our...
View ArticleClik here to view.
テラヴェクティスがBpifranceより190万ユーロの資金を調達
パリ （ビジネスワイヤ） — 世界の主要な感染性疾患とがんに対する新世代の治療用ワクチンと免疫療法の開発を専門とするフランスのバイオテクノロジー企業テラヴェクティスは、Bpifranceより、イノベーション発展支援プログラム（ADI）の一環として、返済可能な前払い金の形で、190万ユーロの助成金を交付されたと発表しました。...
View ArticleClik here to view.
Clik here to view.
Takeda Announces That the First Interim Analysis of the Phase 3 Study of Oral...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the randomized, double-blind, placebo-controlled TOURMALINE-MM1 pivotal Phase 3 trial...
View ArticleClik here to view.
Rosetta Genomics Receives First Patent Allowance in Japan
PRINCETON, N.J. & REHOVOT, Israel Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company received a Notice of...
View ArticleClik here to view.
Labcyte Commends Institute for Molecular Medicine Finland – Pfizer Leukemia...
SUNNYVALE, Calif. Labcyte, a company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between...
View ArticleClik here to view.
The Philippines is the 19th Country to Clear CEL-SCI for Patient Enrollment...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) today announced that the Philippines Regulatory Agency (PFDA) has cleared the Company to commence patient enrollment of the Phase III head and neck...
View ArticleClik here to view.
Clik here to view.
CEL-SCI’s Phase III Head and Neck Cancer Trial Cleared to Begin Patient...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) today announced the Ministry of Health Malaysia has cleared the Company to commence patient enrollment for its Phase III head and neck cancer trial of...
View ArticleClik here to view.
14th Annual International Forum on Consciousness Topic Announced, Conscious...
MADISON, Wis. Join scientists, writers, religious leaders, futurists and other global experts in examining the mysteries of consciousness and how we may participate in shaping our collective future...
View ArticleClik here to view.
CHMP RECOMMENDS JINARC® (TOLVAPTAN) FOR APPROVAL IN EU: THE FIRST...
TOKYO Otsuka Pharmaceutical Co., Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended JINARC® (tolvaptan) for...
View ArticleClik here to view.
TOMI™ Environmental Solutions, Inc. Announces Expansion into the Philippines...
BEVERLY HILLS, Calif. TOMI™ Environmental Solutions, Inc. (“TOMI™” or “the “Company”) (OTCQB: TOMZ), a global bacteria and infectious disease control company, announced today that it has entered...
View ArticleClik here to view.
New Partnership with Meyra Extends Aesynt’s IV Robotics Footprint to the...
CRANBERRY TOWNSHIP, Pa. Aesynt, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, today announced a new strategic partnership with Meyra to market...
View ArticleClik here to view.
Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep® in...
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT:ALNOV), an international specialist in cancer and infectious disease diagnostics, and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Eisai and Merck Enter Collaboration to Explore Novel Combination Regimens of...
TOKYO & KENILWORTH, N.J. Eisai Co., Ltd. and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, through a subsidiary, announced today a clinical trial collaboration to evaluate the...
View Article